Revolade Tablets Specified Drug-use Survey
Recruiting
Observational Study
Aplastic Anemia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 6 – 17
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10 (estimated)
- Sponsor
- Novartis Pharmaceuticals · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a multicenter, single-arm, non-interventional study (NIS) to confirm the safety and efficacy of eltrombopag in Anti-Thymocyte Globulin (ATG) treatment naive pediatric patients with aplastic anemia (AA).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients whose legally acceptable representative has given written consent for cooperation in this survey prior to enrollment in this survey
* Patients aged ≥ 6 years and \< 18 years at the start of treatment with eltrombopag
* Pediatric patients with AA who receive eltrombopa…
Contacts
Novartis Pharmaceuticals
CONTACT